Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

HIV Diagnostics Market – Market Insights

HIV diagnostics plays a major role in HIV prevention, treatment, care, and other support services. The diagnosis of HIV include testing services in health-care facilities, and wide range of community-based approaches along with HIV self-testing.

The global HIV diagnostics market was valued at US$ 3,050.8 million in 2018, and is expected to exhibit a CAGR of 9.2% over the forecast period (2019-2027).

Figure 1. Global HIV Diagnostics Market Value (US$ Mn), by Region, 2018

HIV Diagnostics  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2020)

Rising government initiatives are expected to boost growth of the HIV diagnostics market

HIV diagnostics market is expected to witness significant growth, owing to rising government initiatives, in order to control the HIV infection. For instance, in April 2017, Ministry of Health and Family Welfare, Government of India, launched ‘Test and Treat Policy for HIV’ policy, which is expected to improve longevity and quality of life of those infected with HIV. Moreover, in 2017, Ministry of Health, Sri Lanka initiated National HIV/STI Strategic Plan (NSP) Sri Lanka 2018-2022. This strategic plan include five objectives, which will support NSP’s vision to make country free from new HIV infections, discrimination, and AIDS related deaths.

Increasing demand for home testing HIV diagnosis is encouraging key manufacturers to focus on developing portable, easy-to-use, and rapid diagnosis test. This, in turn, is expected to boost the market growth. For instance, in November 2018, Atomo Diagnostics’ Atomo HIV Self-Test was approved for sale in Australia by the Therapeutic Goods Administration (TGA). It is the first and only diagnostic self-test for HIV to receive approval from Australia’s national regulator.

HIV diagnostics market is expected to witness significant growth, owing to increasing adoption of agreement and collaborations strategies by the market players. For instance, in September 2019, Mylan N.V. and Atomo Diagnostics entered into partnership. Under the partnership Mylan gained commercialization rights for Atomo’s HIV rapid diagnostic in Africa, Asia, Middle East, the Commonwealth of Independent States (CIS), and Latin America.

Rising number of HIV cases, which are undiagnosed or late diagnosed are driving demand for HIV diagnostics, which is further expected to bolster HIV diagnostics market growth over the forecast period. For instance, according to the European Centre for Disease Prevention and Control (ECDC) report 2017, around 51% of all HIV cases were diagnosed late, and around 28% had advanced HIV infection, when diagnosed in the Europe in 2015. Moreover, the proportion of those late diagnosis was over 50% in nine European countries, which include Austria, Estonia, Greece, Italy, Latvia, Lithuania, Romania, Slovenia, and Sweden.

Figure 2. Global HIV Diagnostics Market Share (%), by Product Type, 2019 and 2027

HIV Diagnostics  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2020)

HIV Diagnostics Market - Regional Analysis

North America held a dominant position in the global HIV diagnostics market in 2018, owing to increasing product approval in the region. For instance, in November 2019, Vela Diagnostics received de novo authorization by the U.S. Food and Drug Administration (FDA) for its Sentosa SQ HIV-1 Genotyping Assay developed for detection of HIV-1 genomic drug resistance mutations (DRMs). Moreover, in May, 2019, Abbott Laboratories received the World Health Organization's Prequalification approval (WHO PQ) for m-PIMA HIV-1/2 VL, the first point-of-care viral load diagnostic test. The portable molecular point-of-care test is designed specifically for usage in resource-limited settings. The prequalification status qualifies the product for purchase by agencies of the United Nation.

Moreover, Europe is expected to witness significant growth in the HIV diagnostics market during the forecast period, owing to rising product launches by the key players. For instance, in July 2018, Abbott Laboratories, launched m-PIMA HIV-1/2 VL, the first point-of-care viral load diagnostic test at the International AIDS Conference, held in Amsterdam in 2018.

Key Players

Major players operating in the global HIV diagnostics market include Abbott Laboratories, Bio-Rad Laboratories, Inc., Hologic, Inc., Siemens Healthineers, Roche AG, Beckman Coulter Inc., OraSure Technologies, Inc., Becton, Dickinson and Company, Merck KGaA, Chembio Diagnostic Systems, Inc., Zyomyx Incorporation, Bristol –Myres Squibb, Janssen Therapeutic, QIAGEN N.V., and ViiV Healthcare Ltd.

Acquired Immunodeficiency Syndrome (AIDS) is caused by human immunodeficiency virus (HIV). HIV diagnosis tests are carried out to detect the presence of the virus. HIV diagnosis can be performed by blood test, saliva test, viral load test, though the most efficient test results are achieved by Enzyme Linked Immunosorbent Assay (ELISA) test initially and Western Bloat Method. ELISA test, which is enzyme linked immunosorbent assay, uses the antibodies to identify the substance and the western blot technique is used to detect anti –HIV antibodies in the human serum sample.

Market Dynamics

Increasing prevalence of HIV are expected to propel global demand for HIV diagnostics over the forecast period. For instance, according to the UNAIDS 2019 report, number of HIV cases increased from 37.2 million to around 37.9 million globally, from the year 2017 and 2018 respectively. Moreover, according to the UNAIDS 2019 report, around 1.7 million new cases of people globally living with HIV was reported in 2018.

Increasing collaborations and acquisitions by the market players are expected to drive the market growth over the forecast period. For instance, in 2016, Abbott Laboratories acquired Alere Inc, a manufacturer of rapid point-of-care diagnostic tests. The acquisition was done to add tests products for infectious diseases such as HIV, tuberculosis, malaria, influenza to Abbott Laboratories’ suite of products for testing genetic mutations and to boost diagnostics offerings of the company.

Moreover, rising product launches by the market players is expected to propel the market growth over the forecast period. For instance, in 2014, BD Biosciences, a segment of BD (Becton, Dickinson and Company) launched BD FACSPresto near patient CD4 counter system for HIV/AIDS patients, which provide lymphocytes and hemoglobin (Hb) concentration in blood samples to stage and monitor HIV/AIDS patients. Moreover, in July 2017, bioLytical Laboratories launched INSTI HIV Self-Test in pharmacies across the Netherlands, thereby providing access to HIV tests for early diagnosis. The INSTI product line is 99% accurate and provides test results in 60 seconds or less. Moreover, the company also offers contract services to adapt the INSTI platform to meet custom functional and technical diagnostic testing requirements.

Key features of the study:

  • This report provides in-depth analysis of the HIV diagnostics market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2019-2027), considering 2018 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global HIV diagnostics market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as part of this study include Abbott Laboratories, Bio-Rad Laboratories, Inc., Hologic, Inc., Siemens Healthineers, Roche AG, Beckman Coulter Inc., OraSure Technologies, Inc., Becton, Dickinson and Company, Merck KGaA, Chembio Diagnostic Systems, Inc., Zyomyx Incorporation, Bristol –Myres Squibb, Janssen Therapeutic, QIAGEN N.V., and ViiV Healthcare Ltd
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding their future product launches, technology upgradation, market expansion, and marketing tactics
  • The global HIV diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the HIV diagnostics market

Detailed Segmentation:

  • Global HIV Diagnostics Market, By Product Type:
    • Instruments
    • Reagents & Kits
  • Global HIV Diagnostics Market, By Test Type:
    • Screening
      • Third Generation (Antibody Test)
        • Laboratory-based
        • Point-of-Care
      • Fourth Generation (Antibody-Antigen (Ab/Ag) Test)
        • Laboratory-based
        • Point-of-Care
      • Others
    • Differentiation & Confirmation Test
    • Monitoring Test
      • CD4 Tests
      • Viral Load Tests
  • Global HIV Diagnostics Market, By End User:
    • Hospitals and Clinics
    • Diagnostic Laboratories
    • Home Care Settings
    • Others
  • Global HIV Diagnostics Market, By Region:
    • North America
      • By Product Type:
        • Instruments
        • Reagents & Kits
      • By Test Type:
        • Screening
          • Third Generation (Antibody Test)
            • Laboratory-based
            • Point-of-Care
          • Fourth Generation (Antibody-Antigen (Ab/Ag) Test)
            • Laboratory-based
            • Point-of-Care
          • Others
        • Differentiation & Confirmation Test
        • Monitoring Test
          • CD4 Tests
          • Viral Load Tests
      • By End User:
        • Hospitals and Clinics
        • Diagnostic Laboratories
        • Home Care Settings
        • Others
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Product Type:
        • Instruments
        • Reagents & Kits
      • By Test Type:
        • Screening
          • Third Generation (Antibody Test)
            • Laboratory-based
            • Point-of-Care
          • Fourth Generation (Antibody-Antigen (Ab/Ag) Test)
            • Laboratory-based
            • Point-of-Care
          • Others
        • Differentiation & Confirmation Test
        • Monitoring Test
          • CD4 Tests
          • Viral Load Tests
      • By End User:
        • Hospitals and Clinics
        • Diagnostic Laboratories
        • Home Care Settings
        • Others
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product Type:
        • Instruments
        • Reagents & Kits
      • By Test Type:
        • Screening
          • Third Generation (Antibody Test)
            • Laboratory-based
            • Point-of-Care
          • Fourth Generation (Antibody-Antigen (Ab/Ag) Test)
            • Laboratory-based
            • Point-of-Care
          • Others
        • Differentiation & Confirmation Test
        • Monitoring Test
          • CD4 Tests
          • Viral Load Tests
      • By End User:
        • Hospitals and Clinics
        • Diagnostic Laboratories
        • Home Care Settings
        • Others
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type:
        • Instruments
        • Reagents & Kits
      • By Test Type:
        • Screening
          • Third Generation (Antibody Test)
            • Laboratory-based
            • Point-of-Care
          • Fourth Generation (Antibody-Antigen (Ab/Ag) Test)
            • Laboratory-based
            • Point-of-Care
          • Others
        • Differentiation & Confirmation Test
        • Monitoring Test
          • CD4 Tests
          • Viral Load Tests
      • By End User:
        • Hospitals and Clinics
        • Diagnostic Laboratories
        • Home Care Settings
        • Others
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product Type:
        • Instruments
        • Reagents & Kits
      • By Test Type:
        • Screening
          • Third Generation (Antibody Test)
            • Laboratory-based
            • Point-of-Care
          • Fourth Generation (Antibody-Antigen (Ab/Ag) Test)
            • Laboratory-based
            • Point-of-Care
          • Others
        • Differentiation & Confirmation Test
        • Monitoring Test
          • CD4 Tests
          • Viral Load Tests
      • By End User:
        • Hospitals and Clinics
        • Diagnostic Laboratories
        • Home Care Settings
        • Others
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type:
        • Instruments
        • Reagents & Kits
      • By Test Type:
        • Screening
          • Third Generation (Antibody Test)
            • Laboratory-based
            • Point-of-Care
          • Fourth Generation (Antibody-Antigen (Ab/Ag) Test)
            • Laboratory-based
            • Point-of-Care
          • Others
        • Differentiation & Confirmation Test
        • Monitoring Test
          • CD4 Tests
          • Viral Load Tests
      • By End User:
        • Hospitals and Clinics
        • Diagnostic Laboratories
        • Home Care Settings
        • Others
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Abbott Laboratories*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Bio-Rad Laboratories, Inc.
    • Hologic, Inc.
    • Siemens Healthineers
    • Roche AG
    • Beckman Coulter Inc.
    • OraSure Technologies, Inc.
    • Becton, Dickinson and Company
    • Merck KGaA
    • Chembio Diagnostic Systems, Inc.
    • Zyomyx Incorporation
    • Bristol –Myres Squibb
    • Janssen Therapeutic
    • QIAGEN N.V.
    • ViiV Healthcare Ltd

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Test Type
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Regulatory Scenario
    • Reimbursement Scenario
    • PEST Analysis
    • PORTER’s Analysis
    • Recent Product Launch
    • Merger and Acquisition Scenario
  4. Global HIV Diagnostics Market, By Product Type, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Instruments
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Reagents & Kits
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  5. Global HIV Diagnostics Market, By Test Type, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Screening
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Third Generation (Antibody Test)
          • Laboratory-based
          • Point-of-Care
        • Fourth Generation (Antibody-Antigen (Ab/Ag) Test)
          • Laboratory-based
          • Point-of-Care
        • Others
    • Differentiation & Confirmation Test
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Monitoring Test
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • CD4 Tests
        • Viral Load Tests
  6. Global HIV Diagnostics Market, By End User, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospital and Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Diagnostic Laboratories
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Home Care Settings
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  7. Global HIV Diagnostics Market, By Region, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2027
    • North America
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
      •  
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  8. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
      • Abbott Laboratories
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Bio-Rad Laboratories, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Hologic, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Siemens Healthineers
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Roche AG
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Beckman Coulter Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • OraSure Technologies, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Becton, Dickinson and Company
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Merck KGaA
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Chembio Diagnostic Systems, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Zyomyx Incorporation
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Bristol –Myres Squibb
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Janssen Therapeutic
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • QIAGEN N.V.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • ViiV Healthcare Ltd
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
    • Analyst Views
  9. Section
    • References
    • Research Methodology
    • About Us and Sales Contact

*Browse 34 market data tables and 25 figures on "HIV Diagnostics Market - Global forecast to 2027”.

Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner